LRRC3C
geneOn this page
Summary
LRRC3C (leucine rich repeat containing 3C, HGNC:40034) is a protein-coding gene on chromosome 17q21.1, encoding Leucine-rich repeat-containing protein 3C (A6NJW4).
Predicted to be located in membrane. Predicted to be active in extracellular matrix and extracellular space.
Source: NCBI Gene 100505591 — RefSeq curated summary.
At a glance
- GWAS associations: 9
- Clinical variants (ClinVar): 52 total
- MANE Select transcript:
NM_001195545
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:40034 |
| Approved symbol | LRRC3C |
| Name | leucine rich repeat containing 3C |
| Location | 17q21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000204913 |
| Ensembl biotype | protein_coding |
| Entrez | 100505591 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000377924
RefSeq mRNA: 1 — MANE Select: NM_001195545
NM_001195545
CCDS: CCDS54121
Canonical transcript exons
ENST00000377924 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001475527 | 39943933 | 39944999 |
| ENSE00001605552 | 39941443 | 39941549 |
| ENSE00003919515 | 39935802 | 39935894 |
| ENSE00003921264 | 39927732 | 39927814 |
Expression profiles
Bgee: expression breadth broad, 33 present calls, max score 49.30.
FANTOM5 (CAGE): breadth broad, TPM avg 0.3653 / max 9.7920, expressed in 207 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 160644 | 0.3653 | 207 |
Top tissues by expression
85 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 49.30 | gold quality |
| stromal cell of endometrium | CL:0002255 | 40.25 | gold quality |
| bone marrow cell | CL:0002092 | 38.51 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| left testis | UBERON:0004533 | 37.14 | gold quality |
| testis | UBERON:0000473 | 36.77 | silver quality |
| vermiform appendix | UBERON:0001154 | 36.77 | silver quality |
| mucosa of stomach | UBERON:0001199 | 36.52 | silver quality |
| left uterine tube | UBERON:0001303 | 36.52 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 36.40 | gold quality |
| fallopian tube | UBERON:0003889 | 35.72 | gold quality |
| bone marrow | UBERON:0002371 | 35.51 | gold quality |
| right testis | UBERON:0004534 | 35.51 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| right uterine tube | UBERON:0001302 | 34.94 | gold quality |
| muscle tissue | UBERON:0002385 | 34.52 | gold quality |
| endocervix | UBERON:0000458 | 34.03 | silver quality |
| fundus of stomach | UBERON:0001160 | 34.01 | gold quality |
| right ovary | UBERON:0002118 | 33.96 | gold quality |
| skin of leg | UBERON:0001511 | 33.90 | silver quality |
| islet of Langerhans | UBERON:0000006 | 33.79 | gold quality |
| prefrontal cortex | UBERON:0000451 | 33.10 | silver quality |
| zone of skin | UBERON:0000014 | 32.63 | gold quality |
| uterine cervix | UBERON:0000002 | 32.60 | silver quality |
| urinary bladder | UBERON:0001255 | 32.37 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| body of stomach | UBERON:0001161 | 31.69 | silver quality |
| lymph node | UBERON:0000029 | 31.53 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.66 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Based on our results and published findings on GSDMA, GSDMB, LRRC3C, and related proteins, we propose that this locus in part affects IBD susceptibility via effects on apoptosis and cell proliferation (PMID:26484354)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Lrrc3c | ENSMUSG00000086545 |
| rattus_norvegicus | Lrrc3c | ENSRNOG00000069314 |
Paralogs (22): IGFALS (ENSG00000099769), TLR8 (ENSG00000101916), LRRC17 (ENSG00000128606), RXFP2 (ENSG00000133105), CD180 (ENSG00000134061), TLR4 (ENSG00000136869), TLR2 (ENSG00000137462), LRRC32 (ENSG00000137507), LRRC3 (ENSG00000160233), LRRC53 (ENSG00000162621), TLR3 (ENSG00000164342), VASN (ENSG00000168140), RXFP1 (ENSG00000171509), NRROS (ENSG00000174004), TLR10 (ENSG00000174123), TLR1 (ENSG00000174125), TLR6 (ENSG00000174130), LRRC3B (ENSG00000179796), TSKU (ENSG00000182704), TLR5 (ENSG00000187554), TLR7 (ENSG00000196664), LRIT2 (ENSG00000204033)
Protein
Protein identifiers
Leucine-rich repeat-containing protein 3C — A6NJW4 (reviewed: A6NJW4)
All UniProt accessions (1): A6NJW4
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Similarity. Belongs to the LRRC3 family.
RefSeq proteins (1): NP_001182474* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001611 | Leu-rich_rpt | Repeat |
| IPR003591 | Leu-rich_rpt_typical-subtyp | Repeat |
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
| IPR050541 | LRR_TM_domain-containing | Family |
Pfam: PF13855
UniProt features (9 total): repeat 3, domain 2, signal peptide 1, chain 1, transmembrane region 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NJW4-F1 | 79.40 | 0.54 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 156
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 3 (showing top):
ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_NEGATIVE, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY, chr17q21
GO Biological Process (0):
GO Molecular Function (2): signaling receptor activity (GO:0038023), protein binding (GO:0005515)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| molecular transducer activity | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
410 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LRRC3C | ZPBP2 | Q6X784 | 718 |
| LRRC3C | GSDMB | Q8TAX9 | 617 |
| LRRC3C | ORMDL3 | Q8N138 | 606 |
| LRRC3C | GSDMA | Q96QA5 | 598 |
| LRRC3C | CDRT15L2 | A8MXV6 | 572 |
| LRRC3C | TRAPPC12 | Q8WVT3 | 525 |
| LRRC3C | TMEM86A | Q8N2M4 | 485 |
| LRRC3C | TBC1D28 | Q2M2D7 | 480 |
| LRRC3C | IKZF3 | Q9UKT9 | 465 |
| LRRC3C | CCDC144A | A2RUR9 | 450 |
| LRRC3C | SLC35G6 | P0C7Q6 | 449 |
| LRRC3C | SLC35G3 | Q8N808 | 448 |
| LRRC3C | SPDYE4 | A6NLX3 | 446 |
| LRRC3C | OR3A2 | P47893 | 445 |
| LRRC3C | CHCT1 | Q86WR6 | 436 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DLG1 | LRRC3C | psi-mi:“MI:0407”(direct interaction) | 0.440 |
BioGRID (1): S (Reconstituted Complex)
ESM2 similar proteins: A2AIG8, A5D7H1, A6H7A0, A6NFX1, A6NJW4, A8MUP2, A8MXK1, B0BMW8, O35393, O54804, O73884, P01135, P35790, P52875, P57791, Q00961, Q01098, Q01134, Q06922, Q08DW9, Q0P5M9, Q0VDI3, Q14728, Q14957, Q15768, Q2M1K6, Q3UGX3, Q4R7M4, Q4V899, Q5E9H2, Q5M7U7, Q5R6I6, Q5RCI5, Q5ZI20, Q7TPB4, Q8BZH0, Q8IVW8, Q8N431, Q8NBA8, Q8R2R5
Diamond homologs: A3KNN3, A4IIW9, A6H789, A6H793, A6NJW4, A8WHP9, E9Q7T7, O46379, O75093, O75094, O88280, O94769, P21793, P24014, P51884, P51885, P51886, P59034, P59035, P83503, Q05443, Q3MHH9, Q5FW85, Q5M7S9, Q65YW8, Q6EMK4, Q6NUI6, Q6R5N8, Q8R5M3, Q8VCH9, Q96PB8, Q9BY71, Q9GKQ6, Q9GZU5, Q9TTE2, Q9WVB4, Q9WVC1, Q9Z0L0, A2AJ76, A4IFA6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
52 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 50 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
327 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:39941548:GT:G | donor_gain | 1.0000 |
| 17:39941546:TCGTG:T | donor_loss | 0.9900 |
| 17:39941549:TG:T | donor_loss | 0.9900 |
| 17:39941550:G:GG | donor_gain | 0.9900 |
| 17:39941550:GT:G | donor_loss | 0.9900 |
| 17:39941551:T:TG | donor_loss | 0.9900 |
| 17:39941552:AA:A | donor_loss | 0.9900 |
| 17:39941545:TTCGT:T | donor_gain | 0.9800 |
| 17:39941546:TCGT:T | donor_gain | 0.9800 |
| 17:39941547:CGT:C | donor_gain | 0.9700 |
| 17:39941548:GTG:G | donor_gain | 0.9700 |
| 17:39941549:TGT:T | donor_gain | 0.9700 |
| 17:39941553:AGTA:A | donor_loss | 0.9600 |
| 17:39941550:GTA:G | donor_gain | 0.9300 |
| 17:39941554:G:C | donor_loss | 0.9300 |
| 17:39942158:G:GT | donor_gain | 0.9000 |
| 17:39943931:A:AG | acceptor_gain | 0.9000 |
| 17:39943932:G:GG | acceptor_gain | 0.9000 |
| 17:39942163:C:A | donor_gain | 0.8700 |
| 17:39943927:CCCCA:C | acceptor_loss | 0.8700 |
| 17:39943929:CCA:C | acceptor_loss | 0.8700 |
| 17:39941554:G:GG | donor_gain | 0.8400 |
| 17:39941553:A:AG | donor_gain | 0.8300 |
| 17:39943932:GATC:G | acceptor_gain | 0.8300 |
| 17:39942804:G:GT | donor_gain | 0.8200 |
| 17:39942161:G:GG | donor_gain | 0.7600 |
| 17:39942160:A:AG | donor_gain | 0.7500 |
| 17:39942769:G:GT | donor_gain | 0.7300 |
| 17:39942719:A:T | donor_gain | 0.7100 |
| 17:39944640:G:T | acceptor_gain | 0.7000 |
AlphaMissense
1734 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:39944392:G:C | W162C | 0.990 |
| 17:39944392:G:T | W162C | 0.990 |
| 17:39944202:T:G | F99C | 0.988 |
| 17:39944274:T:G | F123C | 0.988 |
| 17:39944319:A:T | N138I | 0.983 |
| 17:39944229:T:C | L108S | 0.982 |
| 17:39944235:T:C | L110P | 0.982 |
| 17:39944274:T:C | F123S | 0.982 |
| 17:39944390:T:A | W162R | 0.982 |
| 17:39944390:T:C | W162R | 0.982 |
| 17:39944202:T:C | F99S | 0.981 |
| 17:39944397:G:A | C164Y | 0.981 |
| 17:39944310:T:A | L135H | 0.979 |
| 17:39944099:T:A | C65S | 0.976 |
| 17:39944100:G:C | C65S | 0.976 |
| 17:39944245:T:A | N113K | 0.976 |
| 17:39944245:T:G | N113K | 0.976 |
| 17:39944318:A:T | N138Y | 0.976 |
| 17:39944320:C:A | N138K | 0.976 |
| 17:39944320:C:G | N138K | 0.976 |
| 17:39944386:C:A | N160K | 0.976 |
| 17:39944386:C:G | N160K | 0.976 |
| 17:39944384:A:T | N160Y | 0.975 |
| 17:39944465:T:A | C187S | 0.975 |
| 17:39944466:G:C | C187S | 0.975 |
| 17:39944243:A:T | N113Y | 0.974 |
| 17:39944244:A:T | N113I | 0.974 |
| 17:39944396:T:A | C164S | 0.974 |
| 17:39944397:G:C | C164S | 0.974 |
| 17:39944201:T:C | F99L | 0.973 |
dbSNP variants (sampled 300 via entrez): RS1000273437 (17:39943675 A>T), RS1000331439 (17:39936083 T>C), RS1000503191 (17:39938005 G>A), RS1000550125 (17:39932449 A>G), RS1000570647 (17:39936759 G>A), RS1000787457 (17:39936301 T>G), RS1001017987 (17:39932433 G>A), RS1001178786 (17:39926998 G>C), RS1001335386 (17:39933546 A>G), RS1001523729 (17:39938295 G>A), RS1001526377 (17:39944005 G>T), RS1001630188 (17:39926700 C>T), RS1001861715 (17:39944787 T>C), RS1001888607 (17:39939473 A>G,T), RS1002311108 (17:39945487 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
9 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004131_33 | Inflammatory bowel disease | 2.000000e-26 |
| GCST004132_116 | Crohn’s disease | 1.000000e-16 |
| GCST004133_16 | Ulcerative colitis | 2.000000e-16 |
| GCST004202_2 | Systemic sclerosis | 1.000000e-10 |
| GCST007564_21 | Asthma or allergic disease (pleiotropy) | 4.000000e-17 |
| GCST008103_61 | Bipolar disorder | 6.000000e-07 |
| GCST008916_21 | Asthma | 2.000000e-62 |
| GCST009798_11 | Asthma | 1.000000e-65 |
| GCST010002_123 | Refractive error | 1.000000e-24 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| propionaldehyde | decreases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): systemic sclerosis